CliffsNotes IBM, Boeing Earnings Summaries: Boeing's OK; IBM Is All About What Management Didn't Say

Boeing’s Q1 2026 results were weak, but the company is still progressing on aircraft construction and deliveries, with peak output now expected closer to 2028 and record revenue projected for 2027 above the prior $102-103 billion high. IBM had a decent quarter, and forward EPS estimates continued to rise after the Wednesday night call, though investors were disappointed by software results and disclosure. Overall, the article points to gradual operational improvement at Boeing and modestly constructive estimate revisions at IBM.

Analysis

BA’s setup is less about the quarter and more about the shape of the industrial cycle: the market is still underestimating how long it takes to turn certification, supply-chain normalization, and labor stability into usable delivery capacity. That creates a long-duration operating leverage story, but with a nasty intermediate phase where revenue can inflect faster than cash generation, so equity holders may be forced to finance the climb before they enjoy the margin ramp. The key second-order effect is that every incremental improvement in BA production pulls through suppliers unevenly, rewarding the narrowest bottlenecks first and leaving broader aerospace vendors with lumpy demand until the line is truly stable.

For IBM, the important signal is not the headline quarter but the continued upward drift in forward estimates despite investor frustration. That suggests the market is starting to re-rate IBM as a slow-burn compounding software/infrastructure asset rather than a purely defensive dividend name, but the bar is now higher: execution misses in software disclosure can compress the multiple quickly because the stock is leaning on estimate momentum rather than explosive top-line growth. If that momentum persists for another 2-3 quarters, the stock can grind higher without dramatic revisions; if it stalls, downside is likely to come from multiple compression rather than earnings cuts.

The contrarian angle on BA is that 'ugly GAAP' may be less informative than the market thinks if peak output is still years away. Consensus is likely too focused on near-term accounting noise and too slow to price in the convexity of a multi-year capacity reset, which makes the equity vulnerable to short-term disappointment but attractive on a 12-24 month horizon if delivery execution improves. Conversely, IBM’s mild disappointment could be overdone if investors are penalizing a business that is quietly keeping estimate revisions positive; that makes IBM more interesting as a quality sleeper than as a momentum trade.

Key Decisions for Investors

• BA: stay patient, but only add on post-earnings weakness; prefer 6-12 month upside exposure via call spreads rather than outright stock until delivery cadence is visibly stable. Risk/reward improves if the market keeps pricing in permanent under-earning while revenue normalizes.
• BA/FDX-like industrial basket pair: long BA vs short a higher-expectations industrial name with less operating leverage to production recovery over 12 months. The thesis is that BA’s multi-year normalization has more room for revision than peers already priced for stability.
• IBM: initiate a modest long on estimate-revision strength with a 3-6 month horizon. The trade works if forward EPS keeps grinding higher; stop if software commentary starts implying the revision cycle has peaked.
• IBM vs defensive IT services/legacy software short basket: long IBM / short a basket of slower-revision enterprise tech names. This isolates the estimate-momentum factor and limits macro beta.
• Avoid chasing BA immediately after positive delivery headlines; the cleaner entry is after any drawdown tied to quarterly noise, because the catalyst path is measured in quarters-to-years, not days.